Another news blurb about the bivalent boosters. I have not yet read the CDC post (second link below), but the bivalent booster does appear to be at least somewhat effective against at least some of the recent variants.
>>>For adults between the ages of 18 and 49, the boosters cut the odds of getting a symptomatic infection caused by the BA.5 subvariant by 52%, and it cut the odds of getting an infection caused by XBB or XBB.1.5 by 49%. For adults ages 50 to 64, the new boosters cut the odds of getting sick with Covid-19 by 43% for BA.5 and 40% for XBB subvariants. For those age 65 and older, the boosters cut the odds of an infection with symptoms by 37% and 43% for BA.5 and XBB subvariants, respectively.
The study authors saw little evidence of waning effectiveness two to three months after people got their shots.<<<
The updated boosters are cutting the risk that a person will get sick from Covid-19 by about half, even against infections caused by the rapidly spreading XBB.1.5 subvariant.
www.cnn.com
This report describes how a bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2–4 monovalent vaccine doses.
www.cdc.gov